Sign up
SOPH

Sophia Genetics SA (NASDAQ: SOPH)

Healthcare · Health Information Services

$7.47+0.02 (+0.27%)

Last close · Nov 18, 2026 · NASDAQ USD

Set alert

The Quantellect read. SOPH rose 0.27% in the Nov 18 session to $7.47. The borrow fee is 4.45%. Three active firms cover the stock as of Nov 19, 2026; three active firms with targets average $10.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuation—

—

MomentumNeutral

RSI (14) 55.5 (overbought above 70, oversold below 30)

Trend—

—

Short interest1.8% of float

FINRA settlement Oct 30, 2026

SOPH price chart

Price $7.47 · As of Nov 18, 2026, 3:59 PM ET

Open full chart →
Price details unavailable for this range.

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First date—
Last date—
Open—
High—
Low—
Close—
Volume—
Plotted bars0

Plotted OHLCV bars

No price bars are available for this range.

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of —

Initial 6M price range summary
Range6M
First close—
Last close—
High—
Low—
Volume—
Open
$7.46Nov 18, 2026 session
Previous close
$7.45Nov 17, 2026 close
Day range
$7.31 – $7.85Nov 18, 2026 session
52-week range—
Volume
607.30KNov 18, 2026 session
Average volume (30 calendar days)—
Market cap—
P/E (TTM)—
Forward P/E—
EPS (TTM)—
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)—

Price history

SOPH · NASDAQ · USD

Split-adjusted · volume in shares

Price history unavailable

Notable price movement

— · Notable price movement not available

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide70High Tide—
Squeeze22Idle—
How the scores work →

Industry comparison

— · Industry comparison not available

Upcoming events

— · Upcoming events not available

Analyst consensus

Buy

0Strong Buy
3Buy
0Neutral
0Sell
0Strong Sell

Based on 3 active firms as of Nov 19, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$7.00
Average$10.00
High$14.00

As of Nov 19, 2026 across 3 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

— · Earnings history not available

Smart-money activity

In the last 60 days: 21 insider sales and 2 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
Insider sellVan Well DaanSell$9.5KForm 4
Insider sellXu ZhenyuSell$31.8KForm 4
Insider sellMenu PhilippeSell$38.4KForm 4
Insider sellHIBBS KATHY LSell$48.5KForm 4
Insider sellCamblong JurgiSell$65.9KForm 4
Insider sellVan Well DaanSell$10.5KForm 4
Insider buyCARDOZA GEORGEBuy$141.2KForm 4
Insider buyMuken RossBuy$137.2KForm 4
Insider sellMenu PhilippeSell$36.3KForm 4
Insider sellXu ZhenyuSell$28.7KForm 4
All smart-money activity →

News and press releases

News and press releases are not available.

All SOPH news →

Company profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in

CEO
Mr. Ross Jordan Muken B.Sc.
Headquarters
Rolle, Switzerland
Employees
415
IPO date
Jul 23, 2021
Sector
Healthcare
Industry
Health Information Services

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.